News - Page 176 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Post published:May 27, 2021
Post category:Press Release

Read more about the article PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations

PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations

Post published:May 27, 2021
Post category:Press Release

Read more about the article MindMed announces shareholder Meeting Results

MindMed announces shareholder Meeting Results

Post published:May 27, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke

Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke

Post published:May 27, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange

Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange

Post published:May 27, 2021
Post category:Press Release

Read more about the article MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing

MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing

Post published:May 26, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Inc. Announces Public Listing on the Canadian Securities Exchange

MYND Life Sciences Inc. Announces Public Listing on the Canadian Securities Exchange

Post published:May 26, 2021
Post category:Press Release

Read more about the article Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development Candidates Across 153 Global Jurisdictions

Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development Candidates Across 153 Global Jurisdictions

Post published:May 26, 2021
Post category:Press Release

Read more about the article Adding to their Expert Team, Albert Labs Announces the Formation and Chairs of its Two Advisory Boards

Adding to their Expert Team, Albert Labs Announces the Formation and Chairs of its Two Advisory Boards

Post published:May 25, 2021
Post category:Press Release

Read more about the article Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

Post published:May 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.